Ocular Melanoma clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for

  • Neoadjuvant Darovasertib in Primary Uveal Melanoma

    Sorry, not currently recruiting here

    This is a Phase 3, randomized, multi-center, open-label study of neoadjuvant darovasertib in subjects with primary non-metastatic uveal melanoma (OptimUM-10)

    Orange 5379513, California 5332921 and other locations

Last updated: